Shanghai Haohai Biological Technology Co., Ltd. (stock code: 06826 for H shares; 688366 for A shares) released a Next Day Disclosure Return dated 1 December 2025. According to the announcement, the outstanding number of H shares remains at 38,529,240 before and after the reported share transactions. Meanwhile, the company’s total A shares stand at 190,203,760, with 3,848,095 designated as treasury shares, resulting in an overall total of 228,733,000 ordinary shares excluding treasury shares.

The disclosure highlights continued share repurchases of H shares that have not yet been canceled. On 1 December 2025, the company repurchased 74,900 H shares at prices ranging between HKD 27.38 and HKD 27.70, with the aggregate repurchase price amounting to HKD 2,061,504. In total, 1,762,100 H shares have been repurchased under the current mandate of 3,914,184 shares authorized in June 2025. All repurchases have been conducted on the market and are within the approved parameters, with no newly issued H shares during this period.